Fenbendazole & Cancer

Home
Notes
Fenbendazole Newsletter
Archive
Leaderboard
About
Comprehensive Clinical Evidence Synthesis Report: Efficacy, Preclinical Mechanisms, and Safety Profile of Curcumin Formulations
Modern cellular and clinical evaluations confirm that curcumin is a natural compound exhibiting a broad multi-target therapeutic profile.
19 hrs ago • Fenbendazole & Cancer
Curcumin and Cancer
Curcuminoids demonstrate broad multi-targeted activity across several pathways crucial to cancer development.
19 hrs ago • Fenbendazole & Cancer
Supplement Information: Turmeric, Curcumin and Cancer
Miracle cure or myth?
19 hrs ago • Fenbendazole & Cancer
Niclosamide and Cancer: Research and Clinical Trials
Three cancer trials are currently active on ClinicalTrials.gov
Oct 20 • Fenbendazole & Cancer
Niclosamide Synergy
Reader requested: Niclosamide. This article discusses in vitro and in vivo preclinical testing (Lab & Animal).
Oct 19 • Fenbendazole & Cancer
Fenbendazole Oncology Case Comparison
Comparing the Diffuse Large B-Cell Lymphoma (DLBCL) case report with the three solid tumor cases (breast, prostate, and melanoma)
Oct 19 • Fenbendazole & Cancer
Small Bowel NET: Appointment Guide
Downloadable PDF file. Includes list of source documents. Reader requested.
Oct 19 • Fenbendazole & Cancer
Niclosamide Prodrugs
Prodrugs overcome bioavailability through several chemical and pharmacokinetic enhancements. Reader requested.
Oct 19 • Fenbendazole & Cancer
Fenbendazole Tubulin Binding [highly technical]
Docking scores let researchers rank compounds by how well they fit the active site relative to a known reference drug.
Oct 19 • Fenbendazole & Cancer
Changes to Our Substack Format Beginning November 1, 2026
Oct 19 • Fenbendazole & Cancer
Comparative Metabolic Disruption and Synergistic Profiling of Fenbendazole (FBZ) in Cancer Models
Preclinical studies and real-world case reports suggest that Fenbendazole represents an intriguing candidate for drug repurposing in oncology.
Oct 18 • Fenbendazole & Cancer
Fenbendazole Lymphoma Case
An elderly patient who achieved significant disease regression after self-administering Fenbendazole.
Oct 18 • Fenbendazole & Cancer
© 2026 Fenbendazole & Cancer · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture